Literature DB >> 17896182

Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression.

Patricia J Champine1, Jacob Michaelson, Bart C Weimer, Danny R Welch, Daryll B DeWald.   

Abstract

We used Affymetrix microarrays to compare gene expression profiles of the metastatic parental breast cancer cell line MDA-MB-435 (435) and the non-metastatic daughter cell line created by the stable expression of the BReast cancer Metastasis Suppressor 1 (BRMS1) gene in 435 cells, MDA-MB-435-BRMS1 (435/BRMS1). Analysis of microarray data provided insight into some of the potential mechanisms by which BRMS1 inhibits tumor formation at secondary sites. Furthermore, due to the importance of the microenvironment, we also examined gene expression under different growth conditions (i.e., plus or minus serum). Expression of 565 genes was significantly (adjusted P-value <0.05) altered regardless of in vitro growth conditions. BRMS1 expression significantly increased multiple major histocompatability complex (MHC) genes and significantly decreased expression of several genes associated with protein localization and secretion. The pattern of gene expression associated with BRMS1 expression suggests that metastasis suppression may be mediated by enhanced immune recognition, altered transport, and/or secretion of metastasis-associated proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17896182      PMCID: PMC2214901          DOI: 10.1007/s10585-007-9092-8

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  35 in total

1.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

2.  Multiple roles for phosphatidylinositol 4-kinase in biosynthetic transport in polarized Madin-Darby canine kidney cells.

Authors:  Jennifer R Bruns; Mark A Ellis; Andreas Jeromin; Ora A Weisz
Journal:  J Biol Chem       Date:  2001-11-09       Impact factor: 5.157

Review 3.  Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application.

Authors:  Carrie W Rinker-Schaeffer; James P O'Keefe; Danny R Welch; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

Review 4.  Rabs and their effectors: achieving specificity in membrane traffic.

Authors:  Bianka L Grosshans; Darinel Ortiz; Peter Novick
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

5.  Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).

Authors:  Rajeev S Samant; Michael T Debies; Douglas R Hurst; Blake P Moore; Lalita A Shevde; Danny R Welch
Journal:  Cancer Lett       Date:  2005-06-22       Impact factor: 8.679

6.  Downregulation of metastasis suppressor genes in malignant pheochromocytoma.

Authors:  Shoichiro Ohta; Edwin W Lai; Alan L Y Pang; Frederieke M Brouwers; Wai-Yee Chan; Graeme Eisenhofer; Ronald de Krijger; Lucia Ksinantova; Jan Breza; Pavel Blazicek; Richard Kvetnansky; Robert A Wesley; Karel Pacak
Journal:  Int J Cancer       Date:  2005-03-10       Impact factor: 7.396

7.  Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication.

Authors:  M M Saunders; M J Seraj; Z Li; Z Zhou; C R Winter; D R Welch; H J Donahue
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

8.  Inhibitory regulation of EGF receptor degradation by sorting nexin 5.

Authors:  Hao Liu; Zu-Qiang Liu; Carol X-Q Chen; Stephen Magill; Yu Jiang; Yong-Jian Liu
Journal:  Biochem Biophys Res Commun       Date:  2006-02-09       Impact factor: 3.575

9.  MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?

Authors:  W Walter; K Lingnau; E Schmitt; M Loos; M J Maeurer
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

10.  Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope.

Authors:  R Sotiriadou; S A Perez; A D Gritzapis; P A Sotiropoulou; H Echner; S Heinzel; A Mamalaki; G Pawelec; W Voelter; C N Baxevanis; M Papamichail
Journal:  Br J Cancer       Date:  2001-11-16       Impact factor: 7.640

View more
  27 in total

Review 1.  Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  FEBS Lett       Date:  2011-08-05       Impact factor: 4.124

2.  Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.

Authors:  Alexandra C Silveira; Douglas R Hurst; Kedar S Vaidya; Donald E Ayer; Danny R Welch
Journal:  Cancer Lett       Date:  2008-12-13       Impact factor: 8.679

3.  Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.

Authors:  Brandon J Metge; Andra R Frost; Judy A King; Donna Lynn Dyess; Danny R Welch; Rajeev S Samant; Lalita A Shevde
Journal:  Clin Exp Metastasis       Date:  2008-06-20       Impact factor: 5.150

4.  A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.

Authors:  Natalya Frolova; Mick D Edmonds; Thomas M Bodenstine; Robert Seitz; Martin R Johnson; Rui Feng; Danny R Welch; Andra R Frost
Journal:  Tumour Biol       Date:  2009-07-16

5.  Linking metastasis suppression with metastamiR regulation.

Authors:  Mick D Edmonds; Douglas R Hurst; Danny R Welch
Journal:  Cell Cycle       Date:  2009-09-23       Impact factor: 4.534

6.  In vitro biophysical, microspectroscopic and cytotoxic evaluation of metastatic and non-metastatic cancer cells in responses to anti-cancer drug.

Authors:  Qifei Li; Lifu Xiao; Sitaram Harihar; Danny R Welch; Elizabeth Vargis; Anhong Zhou
Journal:  Anal Methods       Date:  2015-11-03       Impact factor: 2.896

7.  ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.

Authors:  Amanda F Swindall; Angelina I Londoño-Joshi; Matthew J Schultz; Naomi Fineberg; Donald J Buchsbaum; Susan L Bellis
Journal:  Cancer Res       Date:  2013-01-28       Impact factor: 12.701

8.  Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.

Authors:  Siti Nur Ain Roesley; Randy Suryadinata; Emma Morrish; Anthonius Ricardo Tan; Samah M A Issa; Jonathan S Oakhill; Ora Bernard; Danny R Welch; Boris Šarčević
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

9.  Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.

Authors:  Douglas R Hurst; Yi Xie; Kedar S Vaidya; Alka Mehta; Blake P Moore; Mary Ann Accavitti-Loper; Rajeev S Samant; Ritu Saxena; Alexandra C Silveira; Danny R Welch
Journal:  J Biol Chem       Date:  2008-01-22       Impact factor: 5.157

10.  Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice.

Authors:  Heiko Bugger; Dong Chen; Christian Riehle; Jamie Soto; Heather A Theobald; Xiao X Hu; Balasubramanian Ganesan; Bart C Weimer; E Dale Abel
Journal:  Diabetes       Date:  2009-06-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.